Phase II trials of malignant mesothelioma: a commentary and update

Affiliations

Comment

A Krarup-Hansen. Lung Cancer. 1994 Sep.

. 1994 Sep;11(3-4):305-8.

doi: 10.1016/0169-5002(94)90551-7.

¹ Department of Oncology, Finsen Institute, University Hospital of Copenhagen, Rigshospitalet, Denmark.

No abstract available

Comment on

High dose doxorubicin plus cisplatin in the treatment of unresectable mesotheliomas: report of four cases.
Stewart DJ, Gertler SZ, Tomiak A, Shamji F, Goel R, Evans WK. Stewart DJ, et al. Lung Cancer. 1994 Sep;11(3-4):251-8. doi: 10.1016/0169-5002(94)90545-2. Lung Cancer. 1994. PMID: 7812702
Combination chemotherapy with cisplatin-vinblastine in malignant mesothelioma.
Tsavaris N, Mylonakis N, Karvounis N, Bacoyiannis C, Briasoulis E, Skarlos D, Pavlidis N, Stamatelos G, Kosmidis P. Tsavaris N, et al. Lung Cancer. 1994 Sep;11(3-4):299-303. doi: 10.1016/0169-5002(94)90550-9. Lung Cancer. 1994. PMID: 7812707